Workit Health

Can you believe how quickly #BHT2024 is coming up?! 🎉 We’re coming together to work towards expanding access to mental health and substance use care through #technology and #innovation. Telehealth has transformed the landscape of substance use disorder (SUD) treatment, offering new pathways to care that meet individuals where they are—physically, emotionally, and mentally. This session will explore innovative telehealth approaches that expand access to evidence-based SUD treatment, particularly for populations who face barriers to traditional in-person care. Experts will discuss the benefits and challenges of virtual care models, including increased flexibility, privacy, and continuity of care. Real-world examples will highlight how providers are integrating telehealth with personalized support to improve recovery outcomes, and how policymakers and payers can further support the expansion of these services. Attendees will leave with practical insights on leveraging telehealth to provide accessible, high-quality SUD care. We look forward to seeing you there on November 5th at 1:15pm. Register now: https://hubs.li/Q02W4BvM0

#BHT2024 is right around the corner! Join us as Deborah Adler, CEO of Navigator Healthcare Inc. leads a panel of experts including Workit Health's CMO M. Justin Coffey, MD, DFAPA, FANPA, CHCIO; Ali Haight, LCSW, LISW, LSCSW of Oak Street Health; Rachel Kotok Goldberg of Horizon Blue Cross Blue Shield of New Jersey and NovaWell; and Stephanie Stitt LISW, LICDC of CareSource. We'll be discussing "Meeting People Where They’re at With Telehealth Substance Use Disorder Treatment" from the perspectives of providers, health systems, health plans, and innovators. Join us November 5th at the Arizona Biltmore at the Behavioral Health Tech event for this important panel discussion. https://lnkd.in/gyZZzt_F

Are you at #HLTHUSA? Reach out to Workit Health CEO Gil Kochman, MBA, who is in Las Vegas connecting with other healthcare experts, leaders, and innovators at this vibrant event. Today's agenda is packed with critical topics from AI to healthcare equity to GLP-1s, and attendees span disciplines and roles across wellness industries. https://lnkd.in/eg9vDN_X #HLTHUSA #Healthcare #FutureofHealth

We thank Amanda Latimore, PhD, who led September's Grand Rounds on the topic of "Opioid Use Disorder in Rural and Urban Populations: Addressing Health Disparities in the Context of Telemedicine." Dr. Latimore is a social epidemiologist. She is the Director of the Center for Addiction Research and Effective Solutions (CARES), which engages communities and translates research into action in order to prevent addiction and to address the needs of those impacted by addiction. Dr. Latimore's research has focused on social determinants of health and how they contribute to racial inequalities in healthcare. She has worked closely with the Baltimore City Health Department, as a policy consultant for the American Society of Addiction Medicine - ASAM, and serves as an adjunct assistant professor at the Johns Hopkins Bloomberg School of Public Health and at Georgetown University. Learn more about Dr. Latimore's work in her recent publication, "Primary, Secondary, and Tertiary Prevention of Substance Use Disorders through Socioecological Strategies, which was published in NAM Perspectives in 2023: https://lnkd.in/g7ifBMhZ Workit Health has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit to PAs and NPs who participate in Grand Rounds. All Workit Health staff are welcome to attend these educational sessions.

Substance use is a matter of public health. As cannabis regulations continue to evolve, it's important to take a close look at how these changes impact people's consumption. Workit Health Director of Research Marlene C. Lira co-authored a paper together with Seema Pessar, Rosanna Smart, Tim Naimi, Jason Blanchette, Anne Boustead, and Rosalie Liccardo Pacula, examining many of the policy areas impacting the availability of legal, non-medical cannabis, and the correlating patterns of consumption. Click the link below to read "The association between state cannabis policies and cannabis use among adults and youth, United States, 2002–2019," published in the journal Addiction from the Society for the Study of Addiction. https://lnkd.in/gkrWTa4j

We're counting the days until our panel at #BHT2024! Workit Health's CMO M. Justin Coffey, MD, DFAPA, FANPA, CHCIO will join an incredible panel including Ali Haight, LCSW, LISW, LSCSW of Oak Street Health, Rachel Kotok Goldberg of Horizon Blue Cross Blue Shield of New Jersey and NovaWell, and moderator Deborah Adler. The topic is "Meeting People Where They’re at With Telehealth Substance Use Disorder Treatment," which is vital in digital health. Join us November 5th at the Arizona Biltmore for our panel at the Behavioral Health Tech Conference event! https://lnkd.in/gyZZzt_F

When Workit Health began providing virtual care in 2015, most people we talked to hadn't even heard of telehealth. When we started treating opioid use disorder online in 2017 (after an initial in-person appointment, at that time), we were called on to continuously assure prospective members and other organizations that telehealth treatment was legitimate and legal. Now telehealth has become a critical component of healthcare in America, but many are still unsure of what is possible via virtual care. We're excited for the American Telemedicine Association’s 4th annual Telehealth Awareness Week, September 15-21, 2024, which showcases the ways that virtual care improves access to quality healthcare for all communities. #TelehealthAwarenessWeek #telemedicine https://lnkd.in/eYxbcZw7 

Workit Health co-signed a letter to Congress and the White House, adding our voice to the hundreds of other stakeholders asking them to ensure ongoing access to telehealth prescribing of controlled substances. As we await regulations from the Drug Enforcement Administration, we are dismayed by reports that they plan to significantly limit virtual prescribing. We join the American Telemedicine Association, ATA Action, and our fellow providers and healthcare organizations in calling for Congress and the White House to extend pandemic-era remote prescribing flexibilities for controlled substances for two years. Many Workit Health members rely on the Schedule III controlled substance buprenorphine to treat their opioid use disorder and maintain their quality of life. Protecting their access to this vital medication is at the heart of our mission. https://lnkd.in/etXyZknp

Workit Health is proud and honored to be a quarterfinalist in The Digital Health Hub Foundation - Digital Health Awards. It's fantastic to see so many amazing companies standing with us, innovating digital treatment of mental and behavioral health.

Medication like naltrexone and acamprosate can be an important component of treating alcohol use disorder, but millions of people struggling to quit drinking don't even know that it's an option. Kudos to Eileen B. for reaching out to The New York Times to increase visibility for alcohol use disorder medication.